ConductScience.org, home

Comparison · NCT02618343-e6dc0573

Isopropyl Alcohol vs Ondansetron Group: Number of Subjects That Required Rescue Ondansetron

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Isopropyl Alcohol vs Ondansetron Group: Number of Subjects That Required Rescue Ondansetron. Trial comparisons, record NCT02618343-e6dc0573. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02618343-e6dc0573

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 1000.143wilson
Risk in group 20.07140.01980.226wilson
Risk difference, group 1 minus group 2-0.0714-0.2260.0807newcombe hybrid score
Risk ratio, group 1 over group 2loga group has no participants with the outcome
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to treat, for one fewer participant with the outcome on Isopropyl Alcohol than on Ondansetron Group14from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Isopropyl AlcoholPrehospital nausea patient randomized into the IPA group023OG000
Group 2Ondansetron GroupPrehospital nausea patient randomized to the Ondansetron group228OG001

Outcome

Type
SECONDARY
Title
Number of Subjects That Required Rescue Ondansetron
Description
We will compare the number of times that a subject required ondansetron administration after IPA administration, and the number of times ondansetron repeat dose is required in the control group.
Time frame
15 minutes
Population
EMS Patients

Source ClinicalTrials.gov

Trial

Title
EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron
NCT number
NCT02618343
Phases
NA
Conditions
Nausea
Interventions
IPA, Ondansetron
Lead sponsor
The University of Texas Health Science Center at San Antonio
Results first posted
2021-03-24

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02618343-e6dc0573